论文部分内容阅读
目的评价液基细胞学检测技术(TCT)在妇科宫颈病变细胞学筛查中的临床价值。方法对我院近年来接受宫颈病变筛查的290例患者采用宫颈细胞TCT技术检测,细胞学诊断采用伯塞斯达系统(the Bathesda system,TBS)分级法,对细胞学检查阳性者行阴道镜下多点活检,将细胞学检查结果与活检结果作对比分析。结果细胞学异常阳性检出率9.65%(28/290),其中慢性宫颈炎15例;CINⅠ6例,CINⅡ3例,CINⅢ2例;宫颈鳞癌2例。TCT检查与阴道镜下宫颈组织活检结果符合率高。结论TCT检查能准确反映宫颈病变,对宫颈细胞学检查阳性的患者,应遵循细胞学、阴道镜与组织学检测三阶梯式诊断程序,可及早发现宫颈早期病变,降低宫颈癌的发病率和病死率。
Objective To evaluate the clinical value of liquid-based cytology (TCT) in the screening of gynecological cervical lesions. Methods 290 cases of cervical lesions received screening in our hospital in recent years by cervical cytology TCT detection, cytological diagnosis using the Berststat system (the Bathesda system, TBS) grading, cytology-positive colposcopy Under multi-point biopsy, the results of cytology and biopsy results for comparative analysis. Results The positive rate of cytological abnormalities was 9.65% (28/290), of which 15 cases were chronic cervicitis. There were 6 cases of CINⅠ, 3 cases of CINⅡ, 2 cases of CINⅢ and 2 cases of cervical squamous cell carcinoma. TCT examination and colposcopic cervical biopsy results in line with the high rate. Conclusion TCT can accurately reflect the cervical lesions, cervical cytology positive patients should follow cytology, colposcopy and histological detection three ladder diagnostic procedures, early detection of early cervical lesions and reduce the incidence of cervical cancer and death rate.